Our comparable operating profit in the January-March period was at a good level, in the seasonally smallest quarter, reaching EUR 4.4 million (5.2) and representing 11.1 percent of net sales (13.8).

Cancer research grant funding from the NCI has declined by 31% between January and March 2025 compared with last year, according to a report from the Senate Health, Education, Labor, and Pensions ...